Parecoxib FDA Approval Status
FDA Approved: No
Generic name: Parecoxib
Company: Pfizer Inc.
Treatment for: Pain
Parecoxib sodium is a non-narcotic injectable COX-2 selective analgesic for the treatment of acute pain.
In September 2005, Pfizer Inc. announced the receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA), advising the company that the New Drug Application (NDA) for parecoxib had not been approved.
Development timeline for Parecoxib
| Date | Article |
|---|---|
| Sep 20, 2005 | Pfizer Receives FDA Non-Approvable Letter on Parecoxib |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
